CRH Medical (CRHM) Reports Q2 Revenues Below Consensus

CRH Medical (NYSE: CRHM) reported Q2 revenue for the quarter came in at $27.33 million versus the consensus estimate of $27.81 million.

Edward Wright, Chief Executive Officer of CRH commented, "We are pleased with our strong second quarter results, driven by the integration of our recent GI anesthesia acquisitions and the execution of our operational objectives. We are also very excited to have completed our first Managed Anesthesia Care development program with the recently announced acquisition of 51% of Lake Washington Anesthesia." Wright further stated, "Lastly, of note and as expected; CMS' recently proposed 2019 physician fee schedule does not reference any future changes to GI anesthesia reimbursements."

For earnings history and earnings-related data on CRH Medical (CRHM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c